Unknown

Dataset Information

GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study.


ABSTRACT:

Background and aims

Surveillance programs are strongly recommended in patients with liver cirrhosis for early detection of HCC development. Six-monthly ultrasound sonography is the most reliable and commonly used technique, especially when associated with serum determination of α-fetoprotein, but different score systems have been proposed to overcome the unsatisfactory diagnostic accuracy of α-fetoprotein. The aim of this 12-year prospective study is to compare the gender, age, AFP-L3, AFP, des-gamma-carboxy prothrombin (GALAD) versus age, gender, bilirubin, albumin, and platelets and albumin-bilirubin scores in predicting HCC onset.

Approach and results

A cohort of 545 consecutive patients with compensated advanced chronic liver disease without suspected focal lesions was f

SUBMITTER: Villa E 

PROVIDER: S-EPMC10503687 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature